ANDREW MARTIN: Open Payments
NPI 1316660657 · CHIPPEWA FALLS, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,218 in 41 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $1,218
Food & beverage: $1,036Education: $182
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $465 |
| GENZYME CORPORATION | 11 | $225 |
| ABBVIE INC. | 8 | $177 |
| UCB, Inc. | 5 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Genentech USA, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, NEMLUVIO, Xolair, ADBRY, SKYRIZI.
Industry payments across WI — which companies pay providers there.
